Celesia, B., A. Marino, R. Fontana del Vecchio, R. Bruno, F. Palermo, M. Gussio, G. Nunnari, and B. Cacopardo. “IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?”. Mediterranean Journal of Hematology and Infectious Diseases, Vol. 11, no. 1, Oct. 2019, p. e2019063, doi:10.4084/mjhid.2019.063.